Overview

A Study of a Combination of Four Drugs in Patients With Recent HIV Infection

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if it is safe to give a combination of four anti-HIV drugs to patients recently infected with HIV who have never received anti-HIV treatment. The effects of this combination of drugs on the immune system and the level of HIV in the body are studied also. The four-drug combination includes lamivudine, abacavir, amprenavir, and indinavir.
Phase:
Phase 2
Details
Lead Sponsor:
Glaxo Wellcome
Treatments:
Abacavir
Amprenavir
Indinavir
Lamivudine